CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.

Hulgan T, Raffanti S, Kheshti A, Blackwell RB, Rebeiro PF, Barkanic G, Ritz B, Sterling TR
J Infect Dis. 2005 192 (6): 950-7

PMID: 16107946 · DOI:10.1086/432955

MeSH Terms (17)

Adolescent Adult Aged Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count CD4-Positive T-Lymphocytes Cohort Studies Disease Progression Female HIV Infections Humans Lymphocyte Count Male Middle Aged Prognosis Proportional Hazards Models Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities:

Links